<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement">
 <sec id="FPar2">
  <title>Conflicts of interest</title>
  <p>Rafat Abonour: Steering committee for Celgene, research funding from Celgene, Takeda, and Prothena; Lynne Wagner: consultancy for EveryFit, Gilead, and Janssen; Brian G. M. Durie: consultancy for Takeda and Janssen; Sundar Jagannath: consultancy for Bristol-Myers Squibb, Celgene, Merck, and Novartis, speakers' bureau for MMRF and Medicom; Mohit Narang: consultancy and speakers' bureau for Celgene, speakers' bureau for Janssen; Howard R. Terebelo: consultancy for Celgene, speakers' bureau for Janssen, Takeda, and Pharmacyclics; Cristina J. Gasparetto: consultancy for Celgene, Janssen, and Bristol-Myers Squibb research funding from Celgene, honoraria from Bristol-Myers Squibb, Celgene, Takeda, and Janssen, travel reimbursement from Janssen, Bristol-Myers Squibb, and Celgene; Kathleen Toomey: consultancy for Celgene, speakers' bureau for Myriad Genetics, travel reimbursement from Dava Oncology; James W. Hardin: consultancy for Celgene; Amani Kitali: employment at Celgene; Craig Gibson: employment at Celgene (former); Shankar Srinivasan: employment at Celgene; Arlene S. Swern: employment at Celgene; Robert M. Rifkin: consultancy for Amgen, Boehringer Ingelheim, Celgene, EMD Serono, Sandoz, and Takeda, stock with McKesson.</p>
 </sec>
 <sec id="FPar3">
  <title>Ethical approval</title>
  <p>All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.</p>
 </sec>
 <sec id="FPar4">
  <title>Informed consent</title>
  <p>Informed consent was obtained from all individual participants included in the study.</p>
 </sec>
</notes>
